首页> 美国卫生研究院文献>Biomicrofluidics >An integrated microfluidic platform for size-selective single-cell trapping of monocytes from blood
【2h】

An integrated microfluidic platform for size-selective single-cell trapping of monocytes from blood

机译:集成的微流控平台用于大小选择性地捕获血液中单核细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reliable separation and isolation of target single cells from bodily fluids with high purity is of great significance for an accurate and quantitative understanding of the cellular heterogeneity. Here, we describe a fully integrated single-blood-cell analysis platform capable of size-selective cell separation from a population containing a wide distribution of sizes such as diluted blood sample and highly efficient entrapment of single monocytes. The spiked single U937 cells (human monocyte cell line) are separated in sequence by two different-sized microfilters for removing large cell clumps, white blood cells, and red blood cells and then discriminated by dielectrophoretic force and isolated individually by downstream single-cell trapping arrays. When 2% hematocrit blood cells with a final ratio of 1:1000 U937 cells were introduced under the flow rate of 0.2 ml/h, 400 U937 cells were trapped sequentially and deterministically within 40 s with single-cell occupancy of up to 85%. As a proof-of-concept, we also demonstrated single monocyte isolation from diluted blood using the integrated microfluidic device. This size-selective, label-free, and live-cell enrichment microfluidic single blood-cell isolation platform for the processing of cancer and blood cells has a myriad of applications in areas such as single-cell genetic analysis, stem cell biology, point-of-care diagnostics, and cancer diagnostics.
机译:从体液中以高纯度可靠地分离和分离目标单细胞对于准确定量地了解细胞异质性具有重要意义。在这里,我们描述了一个完全集成的单血细胞分析平台,该平台能够从人口中分离出大小选择性的细胞,该群体包含大小分布较广的样本,例如稀释的血液样本和单核细胞的高效捕获。加标的单个U937细胞(人单核细胞系)通过两个不同尺寸的微滤器依次分离,以去除大细胞团,白细胞和红细胞,然后通过介电泳力进行区分,并通过下游单细胞捕获法单独分离数组。当以0.2μml/ h的流速引入最终比率为1:1000的U937细胞的2%血细胞比容血细胞时,在40s内确定性地依次捕获了400个U937细胞,单细胞占用率高达85%。作为概念验证,我们还演示了使用集成的微流控设备从稀释的血液中分离出单核细胞。这个用于处理癌症和血细胞的大小选择性,无标签,活细胞富集的微流体单血细胞分离平台在单细胞遗传分析,干细胞生物学,点标记法等领域具有众多应用。护理诊断和癌症诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号